Carl Zeiss Meditec’s revenues for the first quarter of its 2020/21 financial year reached €368.9 million, down by 0.2 percent year-on-year in reported terms but up by 2.6 percent after adjustment of currency effects. The overall topline recovery was fueled by the good performance of the Ophthalmic Devices’ business unit ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.